NewsRoom Articles - Page 73 of 232

TuesdayNov 14, 2023 9:30 am

PaxMedica Inc. (NASDAQ: PXMD) Is Hoping to Boost Patient Independence with Potential ASD Treatment Amid Growing Prevalence Rates

PaxMedica is developing PAX-101, which utilizes the company’s proprietary source of suramin sodium, for the treatment of ASD (Autism Spectrum Disorder) There is no FDA-approved treatment for the core symptoms of autism, even though the rates of autism spectrum disorder have jumped significantly from 2000 to 2020 ASD is characterized by deficits in social communication, restricted and repetitive patterns of behavior, and significant impairment in functioning, three core aspects of the disease that PaxMedica aims to address The company announced positive topline results from a Phase 2 study evaluating PAX-101 as a potential treatment for ASD and hopes to replicate…

MondayNov 13, 2023 12:55 pm

How Immunotherapy Is Cementing a Role in Cancer Treatment

After decades of dominating cancer treatment protocols across the globe, surgery, radiation and chemotherapy are facing increased competition from a fourth treatment option: immunotherapy. Miami Cancer Institute’s CEO and executive medical director Dr. Micahel Zinner notes that cancer treatments traditionally involve using surgery to remove as much of the cancerous tumor as possible followed by chemotherapy or radiation to kill off the remaining cancer cells. While these treatments aren’t fully effective and often have many negative side effects, they have saved millions of lives worldwide over the decades. However, some pundits are now referring to immunotherapy, a relatively new cancer…

FridayNov 10, 2023 3:05 pm

UPS Looks to Tap e-Commerce Revenue Through Strategic Acquisitions

The United Postal Service (UPS) recently announced that it will spend more than $1 billion this quarter on the acquisition of two companies to increase its reach in e-commerce and bolster its revenue. Currently the largest parcel delivery firm on the globe, UPS has been grappling with increasing competition from rival delivery companies such as FedEx, DHL, DB Schenker and the federal agency United States Postal Service. In late October, UPS cut its revenue projections for the year citing lower demand in the e-commerce sector. The impending $1 billion acquisitions are most likely an attempt by UPS to boost its…

FridayNov 10, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Among Grant Awardees Selected to Advance Scientific Research on ALS

Clene, a company targeting the treatment of neurodegenerative diseases that severely impact people’s lives, is currently focusing on amyotrophic lateral sclerosis (“ALS”) alongside other neurodegenerative diseases The company’s wholly owned subsidiary, Clene Nanomedicine, and two collaborators, Columbia University and Synapticure, are the recipients of a four-year grant totaling $45.1 million The grant will support an Expanded Access Protocol (“EAP”) study for Clene’s investigational product, CNM-Au8(R) CNM-Au8 is an orally administered gold nanocrystal suspension that is thought to improve mitochondrial health and protect neuronal function to treat neurodegenerative diseases, including ALS The EAP study will give patients who did not initially…

FridayNov 10, 2023 9:00 am

Renovaro Biosciences Inc. (NASDAQ: RENB) CEO Provides Update on Combination with AI Expert GEDiCube Intl Ltd. in Letter to Shareholders

The agreement with GEDiCube rebrands the company as a wholly-owned subsidiary under the name Renovaro.AI The combined company brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early detection, diagnostic insights, and targeted immunotherapies, for cancer and other diseases The AI division intends to launch commercial products for early cancer detection and improved therapy selection in 2024 – rapidly expanding the largely untapped precision medicine market In September, Renovaro Biosciences (NASDAQ: RENB), an advanced, preclinical biotechnology company focused on cell, gene, and immunotherapy, and GEDiCube Intl Ltd., an AI medical technology company, announced a definitive agreement…

ThursdayNov 09, 2023 11:57 am

Brain Cancer Reemergence Could Soon Be Detected Using a Finger-Prick Test

A team of researchers from Nottingham Trent University and the University of Sheffield is developing a first-of-its-kind finger-prick test to test for brain cancer. The research team says the simple test could make it easier to spot recurring brain tumors and even extend the lives of tens of thousands of cancer patients globally. More than 300,000 people worldwide are diagnosed with brain tumors every year, and experts predict that slightly more than 18,000 Americans will lose their lives to brain cancer and central nervous system tumors this year. In addition, even though brain cancer treatments have gotten significantly better over…

WednesdayNov 08, 2023 10:21 am

Meta-Analysis Says Nutraceuticals Show Potential in Acne Treatment

According to a recent meta-analysis by researchers from the Brigham and Women’s Hospital in Boston, nutraceutical supplements may have the potential to treat acne. The meta-analysis reviewed 42 papers covering how various nutraceuticals affect acne and found that they may play a role in acne treatment in the future. However, researchers behind the meta-analysis say prior studies on the matter aren’t enough and more research is necessary to ascertain the connection between nutraceuticals and acne. Titled "Safety and Effectiveness of Oral Nutraceuticals for Treating Acne — A Systematic Review," the paper analyzed studies that had relatively small sample sizes but…

TuesdayNov 07, 2023 3:36 pm

Study Finds Autism Compromises Sleep Quality, Physical Activity in Kids

New research has found that children with disorders on the autism spectrum have lower physical activity levels and worse sleep in comparison to their peers. One of the study’s coauthors, Xiao Liang, stated that the study was driven by results from earlier research as well as his experience as an inclusive education teacher in Hong Kong. Liang, who is a research assistant professor in the rehabilitation sciences department at Hong Kong Polytechnic University, added that he discovered that students with autism spectrum disorders (ASD) had low levels of physical activity during class as well as recess and lunch break. For…

MondayNov 06, 2023 2:17 pm

Sex Hormones Could Influence Alzheimer’s Development, Researchers Say

University of Western Ontario researchers have discovered that sex hormones may play a role in the development of Alzheimer’s disease. The neurodegenerative condition affects roughly 32 million people globally and is characterized by disruptive symptoms such as poor judgment, memory loss and loss of sense of initiative. With two-thirds of Alzheimer’s patients being women, researchers from the University of Western Ontario sought to understand the role of female sex hormones in how the disease develops in the brain. Some researchers posit that women develop Alzheimer’s disease at higher rates because they tend to live longer than men, while others say…

MondayNov 06, 2023 9:00 am

Renovaro Biosciences Inc. (NASDAQ: RENB) Announces Three New Members to Board of Directors as Definitive Agreement with GEDiCube Announced

Renovaro added Avram Miller, Leni Boeren, Ruud Hendriks, to the company's board of directors The three additions bring extensive financial backgrounds that will help as the company ventures into the new agreement with GEDiCube and Renovaro AI branding Avram Miller believes that Renovaro Bioscience, combined with GEDiCube, has the key elements to play a significant role in transforming AI's impact on medicine Renovaro Biosciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid tumors with short life expectancy, recently announced a definitive agreement to combine with the advanced AI Company GEDiCube Intl Ltd., rebranding…